Non-Antigenic Modulation of Antigen Receptor (TCR) Cβ-FG Loop Modulates Signalling: Implications of External Factors Influencing T-Cell Responses.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 May 2023
Historique:
received: 01 05 2023
revised: 23 05 2023
accepted: 24 05 2023
medline: 12 6 2023
pubmed: 10 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

T-cell recognition of antigens is complex, leading to biochemical and cellular events that impart both specific and targeted immune responses. The end result is an array of cytokines that facilitate the direction and intensity of the immune reaction-such as T-cell proliferation, differentiation, macrophage activation, and B-cell isotype switching-all of which may be necessary and appropriate to eliminate the antigen and induce adaptive immunity. Using in silico docking to identify small molecules that putatively bind to the T-cell Cβ-FG loop, we have shown in vitro using an antigen presentation assay that T-cell signalling is altered. The idea of modulating T-cell signalling independently of antigens by directly targeting the FG loop is novel and warrants further study.

Identifiants

pubmed: 37298286
pii: ijms24119334
doi: 10.3390/ijms24119334
pmc: PMC10253556
pii:
doi:

Substances chimiques

Receptors, Antigen, T-Cell, alpha-beta 0
Receptors, Antigen 0
Cytokines 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

FEMS Microbiol Rev. 2015 Jul;39(4):567-91
pubmed: 25940667
Nat Struct Biol. 2003 Dec;10(12):980
pubmed: 14634627
Methods Mol Biol. 2015;1263:243-50
pubmed: 25618350
J Immunol. 2006 Jun 1;176(11):6553-9
pubmed: 16709812
Nat Rev Immunol. 2013 Apr;13(4):227-42
pubmed: 23470321
Mol Immunol. 2002 May;38(14):1039-49
pubmed: 11955596
Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16867-72
pubmed: 15557001
Nature. 2001 Jan 4;409(6816):97-101
pubmed: 11343121
Clin Transplant. 2003 Feb;17(1):69-74
pubmed: 12588325
Nat Immunol. 2011 Jan;12(1):5-9
pubmed: 21169997
J Exp Med. 1999 Nov 1;190(9):1357-62
pubmed: 10544207
Methods. 2013 May 15;61(1):10-7
pubmed: 23603216
Immunity. 2016 Aug 16;45(2):442-56
pubmed: 27521270
J Exp Med. 2002 Jun 3;195(11):1419-31
pubmed: 12045240
J Immunol. 2006 Jun 1;176(11):6812-23
pubmed: 16709841
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):129-34
pubmed: 18165317
Cell. 2002 Dec 27;111(7):967-79
pubmed: 12507424
Nature. 2013 Dec 19;504(7480):446-50
pubmed: 24226770
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Mol Pharmacol. 2014 Jan;85(1):50-61
pubmed: 24107512
Nat Immunol. 2003 Jul;4(7):657-63
pubmed: 12796775
Immunity. 2007 Mar;26(3):357-69
pubmed: 17368054
Hum Reprod Update. 2005 Jul-Aug;11(4):411-23
pubmed: 15817524
J Immunol. 2007 Mar 15;178(6):3668-79
pubmed: 17339464
Eur J Immunol. 2003 Feb;33(2):512-21
pubmed: 12645950
PLoS One. 2012;7(8):e43898
pubmed: 22952803
J Immunol. 2010 Sep 1;185(5):2951-9
pubmed: 20660709
J Immunol. 2007 Sep 1;179(5):2889-98
pubmed: 17709503
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1517-22
pubmed: 25605925
Cell Rep. 2016 Mar 29;14(12):2833-45
pubmed: 26997265

Auteurs

Nicholas Manolios (N)

Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Department of Rheumatology, Westmead Hospital, Sydney, NSW 2145, Australia.

Son Pham (S)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

Guojiang Hou (G)

Department of Rheumatology, Westmead Hospital, Sydney, NSW 2145, Australia.

Jonathan Du (J)

The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

Camelia Quek (C)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

David Hibbs (D)

The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

Articles similaires

Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Natural Killer T-Cells Mice Adipose Tissue Lipid Metabolism
Animals Lung India Sheep Transcriptome

Classifications MeSH